These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23232060)

  • 1. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
    Ho KK; Parnell KM; Yuan Y; Xu Y; Kultgen SG; Hamblin S; Hendrickson TF; Luo B; Foulks JM; McCullar MV; Kanner SB
    Bioorg Med Chem Lett; 2013 Jan; 23(2):569-73. PubMed ID: 23232060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
    Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
    Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 3,4-Dihydrobenzo[
    Li Y; Zhang L; Yang R; Qiao Z; Wu M; Huang C; Tian C; Luo X; Yang W; Zhang Y; Li L; Yang S
    J Med Chem; 2022 Feb; 65(3):1786-1807. PubMed ID: 34985886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
    Lee Y; Jung JI; Park KY; Kim SA; Kim J
    Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNIK inhibition abrogates colorectal cancer stemness.
    Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
    Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insight into TNIK Inhibition.
    Kukimoto-Niino M; Shirouzu M; Yamada T
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of TNIK inhibitors in cancer therapeutics.
    Yamada T; Masuda M
    Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
    Masuda M; Sawa M; Yamada T
    Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
    Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
    Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinase TNIK is an essential activator of Wnt target genes.
    Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
    EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
    Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
    Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
    Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
    Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of benzo[d]oxazol-2(3H)-one derivatives as a new class of TNIK inhibitors for the treatment of colorectal cancer.
    Luo X; Yang R; Li Y; Zhang L; Yang S; Li L
    Bioorg Med Chem Lett; 2022 Jul; 67():128745. PubMed ID: 35447345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor.
    Tan Z; Chen L; Zhang S
    Sci Rep; 2016 Sep; 6():33534. PubMed ID: 27650168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traf2- and Nck-interacting kinase is essential for canonical Wnt signaling in Xenopus axis formation.
    Satow R; Shitashige M; Jigami T; Honda K; Ono M; Hirohashi S; Yamada T
    J Biol Chem; 2010 Aug; 285(34):26289-94. PubMed ID: 20566648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
    Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kβ) inhibitors with selectivity over PI3Kα.
    Kim J; Hong S; Hong S
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6977-81. PubMed ID: 22030027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors.
    Zhang D; Ai J; Liang Z; Li C; Peng X; Ji Y; Jiang H; Geng M; Luo C; Liu H
    Bioorg Med Chem; 2012 Sep; 20(17):5169-80. PubMed ID: 22863529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
    Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
    Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2.
    Hilton S; Naud S; Caldwell JJ; Boxall K; Burns S; Anderson VE; Antoni L; Allen CE; Pearl LH; Oliver AW; Wynne Aherne G; Garrett MD; Collins I
    Bioorg Med Chem; 2010 Jan; 18(2):707-18. PubMed ID: 20022510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.